Label-Free In-Situ Biofilm Analysis (LIBA) System

Award Information
Agency: Department of Energy
Branch: N/A
Contract: DE-FG02-09ER85302
Agency Tracking Number: 91207
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2009
Solicitation Year: 2008
Solicitation Topic Code: 41 b
Solicitation Number: DE-PS02-08ER08-34
Small Business Information
133 N. Altadena Drive, #307, Pasadena, CA, 91107
DUNS: 168312028
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: Y
Principal Investigator
 Naresh Menon
 Dr.
 (626) 381-9974
 nmenon@chromologic.com
Business Contact
 Naresh Menon
Title: Dr.
Phone: (626) 381-9974
Email: nmenon@chromologic.com
Research Institution
N/A
Abstract
The DOE is interested in new instrumentation that can be used to reveal the function roles in biofilms with depth and to identify non-cellular biofilm constituents. Current instrumentation techniques are often destructive and/or prohibitively expensive, and no instruments are capable of real-time in situ biofilm characterization. This project will develop a new technology for the in situ real-time characterization of the functional and compositional properties of a biofilm with depth, as it develops and matures in time. The approach is based on the integration of a novel, label-free optical detection method that uses established spectroscopic techniques. In Phase I a laboratory prototype of the portable biofilm analyzing system will be designed, fabricated, tested, and benchmarked against current analytical tools, in order to demonstrate the feasibility of the approach. Commercial Applications and other Benefits as described by the awardee The label-free platform, with its compact fiber-optic coupling, would enable the study and control of biofilms in their native environment, including underground and underwater environments. A better understanding of biofilms would aid in the engineering of enhanced soil remediation and biological carbon sequestration. In addition, a better understanding of antibiotic resistant biofilms would allow the pharmaceutical industry to develop compounds for the control or mitigation of bacterial infections

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government